Evaluating the role of neuronal nitric oxide synthase-containing striatal interneurons in methamphetamine-induced dopamine neurotoxicity
- PMID: 23575992
- PMCID: PMC3692605
- DOI: 10.1007/s12640-013-9391-6
Evaluating the role of neuronal nitric oxide synthase-containing striatal interneurons in methamphetamine-induced dopamine neurotoxicity
Abstract
Production of nitric oxide (NO) has been implicated in methamphetamine (METH)-induced dopamine (DA) neurotoxicity. The source of this NO has not been clearly delineated, but recent evidence suggests that it arises from activation of neuronal nitric oxide synthase (nNOS), which is selectively expressed in a subpopulation of striatal interneurons. Our objective was to determine whether inhibiting activation of nNOS-containing interneurons in the striatum blocks METH-induced neurotoxicity. These interneurons selectively express the neurokinin-1 (NK-1) receptor, which is activated by substance P. One particular toxin, a conjugate of substance P to the ribosome-inactivating protein saporin (SSP-SAP), selectively destroys neurons expressing the NK-1 receptor. Thus, we examined the extent to which depletion of the nNOS-containing interneurons alters production of NO and attenuates METH-induced neurotoxicity. The SSP-SAP lesions resulted in significant loss of nNOS-containing interneurons throughout striatum. Surprisingly, this marked deletion did not confer resistance to METH-induced DA neurotoxicity, even in areas devoid of nNOS-positive cells. Furthermore, these lesions did not attenuate NO production, even in areas lacking nNOS. These data suggest that nNOS-containing interneurons either are not necessary for METH-induced DA neurotoxicity or produce NO that can diffuse extensively through striatal tissue and thereby still mediate neurotoxicity.
Figures





Similar articles
-
Expression and activity of nitric oxide synthase isoforms in methamphetamine-induced striatal dopamine toxicity.J Pharmacol Exp Ther. 2013 Feb;344(2):511-21. doi: 10.1124/jpet.112.199745. Epub 2012 Dec 10. J Pharmacol Exp Ther. 2013. PMID: 23230214 Free PMC article.
-
Distinct mechanisms mediating methamphetamine-induced neuronal apoptosis and dopamine terminal damage share the neuropeptide substance p in the striatum of mice.Ann N Y Acad Sci. 2006 Aug;1074:135-48. doi: 10.1196/annals.1369.013. Ann N Y Acad Sci. 2006. PMID: 17105911 Free PMC article.
-
Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.J Pharmacol Exp Ther. 1998 Mar;284(3):1040-7. J Pharmacol Exp Ther. 1998. PMID: 9495865
-
Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts.Ann N Y Acad Sci. 2001 Jun;939:366-80. doi: 10.1111/j.1749-6632.2001.tb03646.x. Ann N Y Acad Sci. 2001. PMID: 11462792 Review.
-
[A recent trend in methamphetamine-induced neurotoxicity].Nihon Shinkei Seishin Yakurigaku Zasshi. 2002 Apr;22(2):35-47. Nihon Shinkei Seishin Yakurigaku Zasshi. 2002. PMID: 12050851 Review. Japanese.
Cited by
-
The effect of self-administered methamphetamine on GABAergic interneuron populations and functional connectivity of the nucleus accumbens and prefrontal cortex.Psychopharmacology (Berl). 2022 Sep;239(9):2903-2919. doi: 10.1007/s00213-022-06175-9. Epub 2022 Aug 3. Psychopharmacology (Berl). 2022. PMID: 35920922 Free PMC article.
-
Is there a role for nitric oxide in methamphetamine-induced dopamine terminal degeneration?Neurotox Res. 2014 Feb;25(2):153-60. doi: 10.1007/s12640-013-9415-2. Epub 2013 Aug 6. Neurotox Res. 2014. PMID: 23918001 Free PMC article. Review.
-
Effects of Intestinal Microbiota on Brain Development in Humanized Gnotobiotic Mice.Sci Rep. 2018 Apr 3;8(1):5443. doi: 10.1038/s41598-018-23692-w. Sci Rep. 2018. PMID: 29615691 Free PMC article.
References
-
- Abekawa T, Ohmori T, Koyama T. Effects of nitric oxide synthesis inhibition on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain. J Neural Transm. 1996;103(6):671–680. - PubMed
-
- Bergstrom BP, Garris PA. “Passive stabilization” of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson’s disease: a voltammetric study in the 6-OHDA-lesioned rat. J Neurochem. 2003;87(5):1224–1236. - PubMed
-
- Bittner SE, Wagner GC, Aigner TG, Seiden LS. Effects of a high-dose treatment of methamphetamine on caudate dopamine and anorexia in rats. Pharmacol Biochem Behav. 1981;14(4):481–486. - PubMed
-
- Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker W, Jr, Holson RR. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther. 1994;268(3):1571–1580. - PubMed
-
- Brown JM, Quinton MS, Yamamoto BK. Methamphetamine-induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite. J Neurochem. 2005;95(2):429–436. doi:10.1111/j.1471-4159.2005.03379.x. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous